key: cord-0014506-1e1xujoj authors: Herane-Vives, Andrés; Espinoza, Susana; Sandoval, Rodrigo; Ortega, Lorena; Alameda, Luis; Young, Allan H.; Arnone, Danilo; Hayes, Alexander; Benöhr, Jan title: A Novel Earwax Method to Measure Acute and Chronic Glucose Levels date: 2020-12-10 journal: Diagnostics (Basel) DOI: 10.3390/diagnostics10121069 sha: 21c9b75888edb8d6763e16a9bd6b440ce835f7b1 doc_id: 14506 cord_uid: 1e1xujoj Diabetes is the fourth cause of death globally. To date, there is not a practical, as well as an accurate sample for reflecting chronic glucose levels. We measured earwax glucose in 37 controls. Participants provided standard serum, glycated hemoglobin (HbA(1c)) and earwax samples at two time-points, one month apart. The specimens measured baseline fasting glucose, a follow-up postprandial glucose level and a between sample chronic glucose, calculated using the average level on the two occasions. The baseline earwax sample was obtained using a clinical method and the follow-up using a novel self-sampling earwax device. The earwax analytic time was significantly faster using the novel device, in comparison to the clinical use of the syringe. Earwax accurately reflected glucose at both assessments with stronger correlations than HbA(1c). Follow-up postprandial concentrations were more significant than their respective fasting baseline concentrations, reflecting differences in fasting and postprandial glycemia and more efficient standardization at follow up. Earwax demonstrated to be more predictable than HbA(1c) in reflecting systemic fasting, postprandial and long-term glucose levels, and to be less influenced by confounders. Earwax glucose measurements were approximately 60% more predictable than HbA(1c) in reflecting glycemia over a month. The self-sampling device provided a sample that might accurately reflect chronic glycemia. Chronic diseases account for the largest cause of deaths globally (71%), and diabetes is the fourth among them [1] . Diabetes and other metabolic disorders are characterized by a sustained Few other biological samples may provide glucose concentrations. Earwax may be that specimen. Earwax is an oily secretion present within the auditory ear canal produced by apocrine and sebum glands of the ear (the ceruminous glands) [26] . Acute events mediated by the nervous system (e.g., stress reactions) are unlikely to affect the level of this secretion, since ceruminous glands are not innervated [27] . Similar to the wax produced by bees a bacteriostatic agent capable of storing sugar products (honey) in honeycombs [28, 29] human wax is also capable of accumulating glucose level over long periods and may be immune to the most common strains of the epidermal flora [30, 31] . Furthermore, earwax can be collected from home, without the need for specific storage or transporting conditions. We recently demonstrated that earwax reflects the chronic level of plasma concentrations of cortisol, which provides further support to the hypothesis that this specimen could also mirror peripheral chronic glucose concentrations [32] . Although glucose levels have already been measured using earwax samples elsewhere [33, 34] including in diabetic patients [35] , those studies did not investigate if the level found in this monosaccharide represented its long term systemic concentration. The aim of this study was to validate the use of earwax for measuring long-term glucose concentration by using a novel, self-cleaning outer-ear device which does not require specific technical expertise. We collected two right earwax samples extracted one month apart using two different methods (a conventional clinician-administered method and the earwax self-sampling device). At the same time, two glycemic samples were obtained during fasting (baseline) and after the intake of a standardized meal (follow-up) one month apart and also HbA 1c samples. We hypothesized that (1) the earwax self-sampling device would be an effective method to measure short and chronic glucose levels and a viable alternative to conventional methods. (2) Based on the mild/moderate associations between HbA 1c and glucose levels, we also expected that the novel device would be more reliable in reflecting true glycemic measures. Moreover, we predicted that (3) all follow-up concentrations would be larger than their respective baseline concentration and (4) based on the notion that ceruminous glands are not innervated, we expected that earwax, conversely to HbA 1c and glycemia would not be affected by short and long-term confounders mediated by the nervous system. (5) In comparison to other clinical methods, the earwax self-sampling device would reduce the time needed and cost of extraction and analysis of earwax glucose concentration (EGC). Participants were recruited from staff and student volunteers of Universidad Católica del Norte (UCN) in Coquimbo, Chile, and from its local catchment area by public and internal advertisements. All participants were assessed by the same clinical researcher (S.E). Tables 1-3 describe the sample of thirty-seven healthy participants in detail. All participants were recruited during a Southern Hemisphere winter (between 6th of July and 3rd of August 2018). It has previously been demonstrated that different seasons vary the triglyceride composition of this secretion [36] . Asian people and people with intellectual disabilities were excluded, due to their differences in earwax characteristics [36, 37] . Participants required to be free from medical illnesses (e.g., anemia, diabetes, glucose, lactose intolerance), ear pathologies (e.g., impacted earwax, perforated eardrum), and of any medication at the time of recruitment and in the previous month. Subjects were also excluded if they reported, any illicit substance use or were exposed to any severe stressor during the previous month, according to the DMS-III definition [38] . We were able to conduct a prospective case-control, rather than a prospective cross-sectional study because it has previously been found that earwax weight does not significantly differ between ear sides [32] Participants were interviewed at baseline (day = 1) and a follow-up (day = 30). During the baseline assessment a range of demographic, clinical, and environmental factors were systematically assessed (see Tables 1-3) . These included the frequency and severity of the most common day-to-day environmental disturbances, using the Hassles Scale [35] , and more unexpected environmental factors, such as significant life events, using the Recent Life Changes Questionnaire (RLCQ; Miller and Rahe, 1997) [39] during the month between both visits. Participants also assessed their stress perception during the last four weeks using the Perceived Stress Scale (PSS; Cohen, 1994) [40] . Anthropometric variables, such as weight, height, Body Mass Index (BMI) and waist circumference were also detailed during the final assessment. All psychometric tools were validated in Spanish versions. At baseline, in order to collect a standardized amount of earwax secretion at the time of follow-up, the right ear of enrolled participants was cleaned using the Reiner-Alexander syringe to effectively and safely remove any earwax from outer ears [41] . It is the traditional method used by clinicians for removing impacted earwax. Participants were instructed to avoid using cotton buds or the use of any other cleaning outer-ear method during the follow-up period. During the follow-up visit, participants self-cleaned their right ears using an earwax self-sampling device, according to the manufacturer instructions (www.trears.com) and the wax collected represented the previous four weeks of earwax secretion. δ : at least one unit last week and: any medication, including psychotropic and steroidal medication. ϕ : One alcohol unit is measured as 10 mL or 8 g of pure alcohol. This equals one 25 mL single measure of whisky (Alcohol by volume (ABV) 40%), or a third of a pint of beer (ABV 5-6%) or half a standard (175 mL) glass of red wine (ABV 12%). Table 3 . Self-Administrated Questionnaires. Perceived Stress Scale (PSS), Mean (SD) Morning blood tests were obtained at both baseline and follow up visits. The baseline blood sample was obtained after 8 h of fasting whereas the follow-up sample was taken 2 h after consuming a standardized liquid meal, 236 mL of Ensure Avance ® . FSG and HbA 1c levels were analyzed from baseline samples, PSG and HbA 1c levels were analyzed from the follow-up samples. Chronic glucose level over the preceding one-month period was calculated using the mean between the baseline and the follow-up blood sample of glycemia. Glucose concentration was extracted from earwax by using the hydrophilic fraction (see Supplementary Materials for a detailed description of the methods). On 17th of April 2017, the local ethics committee of Universidad Católica del Norte, Coquimbo, Chile issued a resolution number 75/2017 that approved the conduction of the research. Written informed consent was obtained from all participants. Participants did not receive any financial compensation for taking part in the research. Data were checked for normality using the Kolmogorov-Smirnov statistical test and graphics methods. All values were normally distributed (all p > 0.05). Therefore, we used repeated t-tests for comparing baseline and follow-up levels of all specimens. The long-term glucose concentration estimation was calculated using the mean value between FSG and PSG. Pearson correlations (R) were used to determine the association between the baseline and the follow-up EGC with their respective glycemic sample. R was also used for determining the association between the baseline and the follow-up HbA 1c with their respective glycemic sample. Cohen's criteria for correlations were used: low when R = 0.1-0.3, moderate when R = 0.3-0.5 and high when R = 0.5-1.0 [42] . The coefficient of determination (R 2 ) was used for comparing the predictability for measuring different glucose levels between EGC and HbA 1c . Single linear regression analysis was used to determine the regression line of the association between different glucose samples. This statistical method was also used to determine the association between different specimens and biological and psychological variables. The level of significance was set at p ≤ 0.05 (two-tailed). The sample consisted of 37 young healthy individuals (mean age 29.9 years), 54.1% women of normal weight, BMI, and waist circumference with little exposure to severe hassles or life events (see Tables 1-3 for details). Follow-up postprandial concentrations using all specimens, e.g., EGC, HbA 1c , and glycemia were significantly larger than their respective fasting baseline concentrations (see Table 4 for details). The self-sampling device earwax extraction time was considerably faster (04:37 h) vs. Reiner-Alexander syringe (12:20 h) (see Table 5 for details). While earwax glucose and HbA 1c analytic costs were similar, we found that RT-CGM is a significantly more expensive method for measuring chronic glucose levels (see Table 6 for details). Earwax glucose concentration strongly positively correlated with all glycemic measurements (all R ≥ 0.62, R 2 ≥ 38; p < 0.01). HbA 1c associations with glycemic levels exhibited low to moderate correlations across all the measurements (all R ≤ 0.55, R 2 ≤ 0.30 and 0.10 < p < 0.01) ( Table 7 and Figure 1 ). The strongest observed HbA 1c association was with the mean glycemic level at baseline (R = 0.55, R 2 = 0.30, p < 0.001) and the lowest between follow up HbA 1c and mean blood sugar (R = 0.35, R 2 = 0.12 p = 0.03) ( Table 7 and Figure 1iii .b,iv.b). The lowest correlation between EGC and glycemic levels was at baseline with the mean blood sugar (R = 0.62, R 2 = 0.38, p < 0.01) and the strongest at follow-up with PSG (R = 0.90, R 2 = 0.81 p < 0.001) (see Table 7 and Figure 1ii .a, iii.a). EGC was 59% more accurate in predicting glucose levels than HbA 1c for measuring longitudinal (chronic) glucose concentration over the two time points (Follow-up-EGC/Mean glucose level correlation: R = 0.84, R 2 = 0.71; Follow-up-HbA 1c /Mean glucose level correlation R = 0.35, R 2 = 0.12) (see Table 7 and Figure 1iv .a,b). Earwax samples were not affected by any of the covariates considered (all p > 0.05). HbA 1c levels were affected by age at follow-up (p < 0.01) and tobacco use was negatively associated with FSG (p = 0.01) and PSG levels (p = 0.02). Increasing level of education were associated with increased HbA 1c and PSG levels at follow-up (both p < 0.05) ( Table 8) . One alcohol unit is measured as 10 mL or 8 g of pure alcohol. This equals one 25 mL single measure of whisky (Alcohol by volume (ABV) 40%), or a third of a pint of beer (ABV 5-6%) or half a standard (175 mL) glass of red wine (ABV 12%). ξ : In comparison to those who were in their secondary studies or doing a technical work. In this work we set out to test the validity of earwax for measuring long-term glucose concentration by using a novel self-sampling outer-ear device. The main finding of the study is that by using the earwax self-sampling device, earwax was a more efficient specimen compared to HbA 1c in measuring glycemic levels. Furthermore, glucose measurements differently than HbA 1c , were not affected by any of the covariates considered. Moreover, the novel device proved to be a feasible approach to rapidly extract wax for analysis with substantial time reduction compared to conventional methods. We found that follow-up samples of glycemia, HbA 1c , and EGC were significantly larger in comparison to their respective baseline concentrations. All associations between EGC and cross-sectional and longitudinal glycemic levels showed highly positive correlation coefficients. On the contrary, HbA 1c associations with the same short-and long-term glucose levels only exhibited low to moderate correlations. Earwax samples were up to 59% more predictable than HbA 1c specimens at reflecting the average glucose concentration over the preceding month period. The earwax self-sampling device compared to the Reiner-Alexander syringe significantly reduced the time needed (7:43 h less) to analyze EGC. The novel device uses a dry method of extraction which bypassed the need to dry samples before analysis, a typical step of conventional water bases methods. The earwax self-sampling device processing time is comparable to HbA 1c methods, currently the gold-standard for measuring long-term glucose level without inconveniences and associated costs of bloodletting and significantly faster analysis of glycemic levels. Furthermore, while earwax glucose and HbA 1c analytic costs were similar, RT-CGM is significantly more expensive. The RT-CGM was lately developed to provide a glucose reading and trend levels collected every five minutes for up to seven days. Although RT-CGM may be a useful educational and motivational tool, diabetes self-management that includes the use of RT-CGM is likely to be more time-consuming for patients and force them to focus on different aspects of diabetes. Twice-daily self-monitoring of blood glucose is still required to calibrate the RT-CGM device and to inform treatment decisions in those using prandial insulin. Discrepancies between finger-stick blood glucose and sensor values may distress patients. Furthermore, high and low glucose threshold alarms may be disturbing. It has been reported that these devices produce a large amount of information that patients do not know how to handle it [45, 46] . Nonetheless, HbA 1c and earwax glucose costs must be carefully interpreted since these were estimated in the UK and USA. Therefore, they might not accurately represent their current costs for other countries. Furthermore, the cost of the self-sampling earwax device and of the earwax glucose analysis considered were production costs. Production costs do not reflect the full commercial cost when the product becomes commercially available. In this context, HbA 1c might be the more affordable method for measuring chronic glucose concentrations. However, other advantages of this novel method, such as an increase accuracy in measuring chronic glycemia, the negligible risk of side effects and the practicality of its use, might overcome the potential higher cost. Hence, future clinicians, patients or both might prefer the self-sampling earwax device over HbA 1c as shown in previous work [42] . Nevertheless, the approach requires patients' compliance and meeting the standards of health systems across the world. In situations like the current COVID-19 pandemic this novel approach might be preferable in view of the restrictions in mobility and social contact, which could result in a more efficient way to monitor chronic glycemic levels. Furthermore, in the context of COVID-19, in view of the increase in prevalence of mental health conditions [47] , a device which reliably measures chronic glucose levels unaffected by stress factors might be particularly useful. Future, economic evaluation research study should be conducted to deeply investigate these hypotheses. We found stronger associations than previous studies in the correlations between HbA 1c and fasting and postprandial glucose levels among the general population. Van't Riet et al., (2010) found correlations of only 46% and 33% when fasting plasma glucose and 2 h post-load plasma glucose were correlated with HbA 1c in a large sample of controls [11] . It has been shown that HbA 1c usually shows increased associations with fasting (71%) and postprandial glucose levels (79%) among diabetic patients, rather than in controls [11] . This improved HbA 1c association with the postprandial glycemic level in diabetic patients is, however, smaller than the follow-up ECG/PSG correlation found here. On the other hand, the HbA 1c association with fasting glycemic level in diabetes was exactly the same that the one that we found here between baseline-EGC and FSG. It may be possible that EGC also shows an improved correlation in this metabolic disorder. Future studies may correlate PSG and FSG with EGC in diabetic patients. Differences in the period covered by the baseline and the follow-up earwax sample may explain why the correlation between the baseline EGC and FSG (R = 0.71, p < 0.001) was much smaller than the association found between the follow-up EGC and PSG (R = 0.90, p < 0.001). This might be explained by the fact that only the amount of secreted earwax at the time of follow-up was standardized. Hence, the baseline period covered by the baseline EGC varied among participants and might have been affected by a range of factors. Aside from biological differences in fasting and postprandial glycemic levels, peaks of hyperglycemia, due to episodes of physical activity or stress before their inclusion in the study, might have affected baseline earwax measurements. This result suggests that EGC equally weights episodes of fasting and postprandial glucose levels. Conversely, HbA 1c is indeed greatly influenced by FSG than PSG. People spend more time fasting than eating during 24 h [9] . We also found an increased correlation between HbA 1c and FSG (R = 0.51) than HbA 1c with PSG (R = 0.47). The follow-up EGC may not be completely comparable with PSG. We recently showed that the earwax self-sampling device was significantly more efficient than the Reiner-Alexander syringe at removing earwax from healthy outer ears [48] . This suggests that some residual amount of earwax may have been left by the Reiner-Alexander method we used in this study that could have been extracted by the novel device. This would mean that the follow-up earwax sample extracted by the earwax self-sampling device may have also contained some residual earwax, and thus predominantly, but not exclusively, represented the EGC of the last month. The follow-up HbA 1c may also not be entirely comparable with PSG. HbA 1c is widely used as an index of the average level of glucose concentration over the preceding three months, although several studies have found that HbA 1c is predominantly influenced (75%) by the average concentration of glucose levels of the previous one month [12] . Therefore, both follow-up samples of EGC and HbA 1c predominately, but not exclusively represented the mean blood sugar over the last month. Future studies should investigate the same period of glucose concentration and correlate the mean of blood sugar with a follow-up ECC sample that is obtained after a baseline cleaning procedure that also used the earwax self-sampling device. EGC was better than HbA 1c for reflecting acute levels of glycemia. All correlations between EGC and FSG and PSG were stronger than the observed coefficients when HbA 1c was associated with the same levels of glycemia. Furthermore, EGC showed the largest difference with HbA 1c correlations when EGC was associated with the mean blood sugar studied here. Indeed EGC/mean blood sugar correlation (R) was almost 50% stronger than the HbA 1c association with the same mean of glucose level. Furthermore, earwax was approximately 60% more accurate in predicting chronic glucose levels (R 2 ) than HbA 1c . This suggests that earwax is not only better than HbA 1c for reflecting acute glucose levels, but also for chronic. Future studies may correlate EGC with mean blood sugar over different periods. In relation to confounders, we found, as previous studies have, that HbA 1c levels are affected by age [2] . We also found that HbA 1c was affected by the level of education. Participants' type of employment may likely have explained this. It has been shown that jobs that require highly educated workers are also associated with increased working hours [49] , which, in turn, are associated with increased HbA 1c [22] . Indeed, even though participants included in this study were healthy, they were exposed to a significant number and hassles and life events when compared with other healthy research samples originating from Chile [50] likely affecting their self-reporting of stressful events [40] . However, these events were most likely within the remit of stressful jobs or studies, considering that 43.2% of them were undergraduate students or had graduated from University. We also verified previous results that indicated that smoking decreased FSG and PSG. Earwax, however, was a more stable specimen since its glucose levels were not affected by any short-or long-term covariate studied here. Two samples may appear to be a small number to reflect the average glucose concentration over one month, especially when considering that glucose is a substance with a variable profile of secretion. Indeed, some studies have used the area under the curve formula using several time points of glucose samples across the day for estimating the average concentration in this sugar [51] . The mean between fasting and postprandial glycemic levels, however, has proven to be a predictable index for reflecting the average concentration of glycemia. In fact, this index is also used with diabetic patients. Svendson and co-workers found that the average glucose level derived from approximately 2 to 300 blood measurements from 18 Type 1 diabetes patients correlated almost perfectly (R = 0.96) with HbA 1c [52] . Ozmen et al. found that the mean plasma glycemic level derived from fasting and postprandial plasma glucose levels also correlates strongly with HbA 1c in Type 2 diabetic patients [53] . Recently, the mean between postprandial and fasting glycemic levels was also used for monitor treatment in women with gestational diabetes mellitus [54] . The mean blood sugar between FSG and PSG may be even more valid and reliable for estimating the average glucose concentration among healthy people. Controls present less variability in their 24 hr glucose levels compared to diabetic patients [55] . Nonetheless, it may be more accurate to say that the estimated glucose mean of this study was obtained from longitudinal values, rather than the chronic glucose level. A randomized study, blind to the intervention, may be another way to test the hypothesis that earwax glucose is more predictable than HbA 1c for measuring chronic glucose levels especially if several time points are considered. Inter-individual differences related to participants' abilities to absorb different meal components may have also an effect on their glucose levels [56] . Some studies use the glucose tolerance test after the intake of 75 g of glucose, rather than postprandial levels after the intake of one standardized meal. We used Ensure ® , as standardized meals contain glucose and several other nutrients, which may have different absorption rates, affecting, PSG levels. Moreover, the PSG test that we used has been widely used in several other research projects [57, 58] . This is because, in comparison to normal meals, Ensure ® is easier to absorb due to its liquid characteristics. Furthermore, we excluded any participants with food allergies, such as lactose intolerance, which may have altered the absorption rates of some nutrients. With regards to the differences between plasma and serum, some studies report that plasma glucose is higher than serum glucose, whereas other studies found no difference [59] . The measurement of glucose in serum is not recommended for the diagnosis of diabetes [60] . We did not use FSG or PSG to make any diagnosis, we recruited a sample of healthy participants to investigate their glucose levels using different specimens. Earwax showed to be more predictable than HbA 1c at reflecting acute and chronic glucose levels in healthy people. Earwax was also a more stable specimen since it was not affected by any confounders. Future larger validation longitudinal studies could correlate a higher number of fasting and postprandial plasma glucose samples with EGC and consider randomization to confirm the superiority of earwax methods. The earwax self-sampling device proved to be an effective method to measure EGC and may be utilized in diabetes and other metabolic disorders. EGC using the novel device may be a harmless, economic, and suitable test for measuring long-term glucose concentrations. A., and R.S. had role in the design and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. Monitoring health for the SDGs Pitfalls in the use of HbA1c as a diagnostic test: The ethnic conundrum Acute Effect of Cigarette Smoking on Glucose Tolerance and Other Cardiovascular Risk Factors A link between hypertension obesity and glucose intolerance A longitudinal study of body mass index and lens opacities Feasibility and acceptability of continuous glucose monitoring and accelerometer technology in exercising individuals with type 2 diabetes Is There a Relationship between Mean Blood Glucose and Glycated Hemoglobin? Relationship between HbA1c and indices of glucose tolerance derived from a standardized meal test in newly diagnosed treatment naive subjects with Type 2 diabetes Contributions of fasting and postprandial glucose to hemoglobin A1c Defining the Relationship Between Plasma Glucose and HbA1c: Analysis of glucose profiles and HbA1c in the Diabetes Control and Complications Trial Relationship Between A1C and Glucose Levels in the General Dutch Population Clinical Applications of a Mathematical Concept Tests of glycemia in diabetes Role of HbA1c in the Screening of Diabetes Mellitus in a Korean Rural Community Correlation of Glucose Regulation and Hemoglobin AIcin Diabetes Mellitus HbA1c and Risk of Severe Hypoglycemia in Type 2 Diabetes Hypoglycemia in Patients With Type 2 Diabetes Mellitus Correlates of Quality of Life in Older Adults with Diabetes Increased Mortality of Patients with Diabetes Reporting Severe Hypoglycemia Increased plasma malondialdehyde and fructosamine in iron deficiency anemia: Effect of treatment The inherited disorders of haemoglobin: An increasingly neglected global health burden Long working hours and skipping breakfast concomitant with late evening meals are associated with suboptimal glycemic control among young male Japanese patients with type 2 diabetes A1C Versus Glucose Testing: A Comparison Primary care use of laboratory tests in Spain: Measurement through appropriateness indicators Economic Analysis of Requests for Laboratory Tests in Primary Health Care Centers Histology and cytochemistry of human skin. IX. The distribution of non-specific esterases Human ceruminous gland innervation Beeswax: A minireview of its antimicrobial activity and its application in medicine. Asian Pac The Antimicrobial Activity of Some Honey Bee Products and some Saudi Folkloric Plant Extracts Human ceruminous gland: Ultrastructure and histochemical analysis of antimicrobial and cytoskeletal components Antibacterial and antifungal properties of human cerumen Measuring Earwax Cortisol Concentration using a non-stressful sampling method Carbohydrate composition of glycopeptides from the human cerumen Isolation and partial characterization of a glycopeptide from cerumen Glucose content of ear wax in patients with latent and manifest diabetes mellitus Production Rate and Composition of Cerumen Incidence of excessive/impacted cerumen in individuals with mental retardation: A longitudinal investigation DSM-III: The 3d edition of the Diagnostic and Statistical Manual of Mental Disorders from the American Psychiatric Association Life changes scaling for the 1990s The safety and effectiveness of different methods of earwax removal: A systematic review and economic evaluation Statistical Power Analysis for the Behavioral Sciences The cost of treating diabetic ketoacidosis in the UK: A national survey of hospital resource use The cost of repetitive laboratory testing for chronic disease Advantages and Disadvantages of Realtime Continuous Glucose Monitoring in People with Type 2 Diabetes Continuous Glucose Monitoring: An Endocrine Society Clinical Practice Guideline The prevalence of psychological consequences of COVID-19: A systematic review and meta-analysis of observational studies A Self-Sampling Earwax Device A Novel Earwax Self-Sampling Device: A Feasibility Study Long working hours and occupational stress-related cardiovascular attacks among middle-aged workers in Japan Short-term and long-term measures of cortisol in saliva and hair in atypical and non-atypical depression Nonfasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetes Glycosylated haemoglobin and steady-state mean blood glucose concentration in type 1 (insulin-dependent) diabetes A simple way to estimate mean plasma glucose and to identify Type 2 diabetic subjects with poor glycaemic control when a standardized HbA1cassay is not available Insulin detemir versus glyburide in women with gestational diabetes mellitus Glycaemic instability is an underestimated problem in Type II diabetes Continuous Glucose Profiles in Healthy Subjects under Everyday Life Conditions and after Different Meals A Randomized Prospective Trial Comparing a Defined Formula Diet, Corticosteroids, and a Defined Formula Diet Plus Corticosteroids in Active Crohn's Disease Interaction between fed gastric media (Ensure Plus ® ) and different hypromellose based caffeine controlled release tablets: Comparison and mechanistic study of caffeine release in fed and fasted media versus water using the USP dissolution apparatus 3 Blood Glucose Measurement: Is Serum Equal to Plasma? American Diabetes Association Standards of Medical Care in Diabetes-2010 The views expressed are those of the author(s) and not necessarily those of University College London, King's College London, and Universidad Católica del Norte. We are grateful to Anthony Cleare, Patricia Gómez, Margarita Rivas, and Pilar Durruty for contributing to this study and all participants of this study for their support. The funders had no role in the conduct of the study, collection, management, and analysis of the data. Publisher's Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.